Literature DB >> 2758596

Radioimmunoassay of beta-microseminoprotein, a prostatic-secreted protein present in sera of both men and women.

P A Abrahamsson1, C Andersson, T Björk, P Fernlund, H Lilja, A Murne, H Weiber.   

Abstract

We describe a simple radioimmunoassay of beta-microseminoprotein, one of the three most abundant secretory proteins of the prostate gland. The detection limit of the assay is 1 microgram/L, and its precision, expressed as the total coefficient of variation, is less than 10% for values between 10 and 150 micrograms/L. Using this assay, we found that beta-microseminoprotein immunoreactivity was present in sera from both sexes at about the same concentration. The protein detected had the same molecular size on gel chromatography as the protein isolated from seminal plasma, and dilution curves for the sera paralleled that for the pure protein. The findings suggest that beta-microseminoprotein is present in serum of healthy subjects of both sexes and that it originates in tissue other than the prostate gland. The range of the serum concentration was 0-10.6 micrograms/L (median 4.1) for 51 healthy adult women and 1.1-14.7 micrograms/L (median 6.2) for 35 healthy adult men not older than 40 years. In males with prostatic cancer the concentration in serum was highly variable and often greatly increased. The concentration of beta-microseminoprotein was correlated with that of creatinine in serum, suggesting that the protein is eliminated--at least partly--from the circulation by glomerular filtration. Little of the protein was present in the urine of women. In urine from men the concentration was high and variable, probably because of local contribution from the prostate gland to the urethral urine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758596

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.

Authors:  Katharina Braun; Daniel D Sjoberg; Andrew J Vickers; Hans Lilja; Anders S Bjartell
Journal:  Eur Urol       Date:  2015-05-13       Impact factor: 20.096

2.  beta-Microseminoprotein binds CRISP-3 in human seminal plasma.

Authors:  Lene Udby; Ake Lundwall; Anders H Johnsen; Per Fernlund; Camilla Valtonen-André; Anna M Blom; Hans Lilja; Niels Borregaard; Lars Kjeldsen; Anders Bjartell
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

3.  Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.

Authors:  Robert J Klein; Christer Halldén; Angel M Cronin; Alexander Ploner; Fredrik Wiklund; Anders S Bjartell; Pär Stattin; Jianfeng Xu; Peter T Scardino; Kenneth Offit; Andrew J Vickers; Henrik Grönberg; Hans Lilja
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-27

4.  A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.

Authors:  Kevin M Waters; Daniel O Stram; Loic Le Marchand; Robert J Klein; Camilla Valtonen-André; Mari T Peltola; Laurence N Kolonel; Brian E Henderson; Hans Lilja; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-24       Impact factor: 4.254

5.  Beta microseminoprotein is not a prostate-specific protein. Its identification in mucous glands and secretions.

Authors:  H Weiber; C Andersson; A Murne; G Rannevik; C Lindström; H Lilja; P Fernlund
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

6.  Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.

Authors:  Xing Xu; Camilla Valtonen-André; Charlotta Sävblom; Christer Halldén; Hans Lilja; Robert J Klein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08       Impact factor: 4.254

7.  The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor.

Authors:  H von der Kammer; C Jurincic-Winkler; R Horlbeck; K F Klippel; H U Pixberg; K H Scheit
Journal:  Urol Res       Date:  1993-05

8.  Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids.

Authors:  Jonathan R Reeves; Jim W Xuan; Katerina Arfanis; Catherine Morin; Seema V Garde; Marcia T Ruiz; Jan Wisniewski; Chandra Panchal; Jerome E Tanner
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.

Authors:  Anders S Bjartell; Hikmat Al-Ahmadie; Angel M Serio; James A Eastham; Scott E Eggener; Samson W Fine; Lene Udby; William L Gerald; Andrew J Vickers; Hans Lilja; Victor E Reuter; Peter T Scardino
Journal:  Clin Cancer Res       Date:  2007-07-15       Impact factor: 12.531

10.  Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.

Authors:  Liisa Sjöblom; Outi Saramäki; Matti Annala; Katri Leinonen; Janika Nättinen; Teemu Tolonen; Tiina Wahlfors; Matti Nykter; G Steven Bova; Johanna Schleutker; Teuvo L J Tammela; Hans Lilja; Tapio Visakorpi
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.